Packaged Foods
Compare Stocks
4 / 10Stock Comparison
NOMD vs CAG vs CPB vs HRL
Revenue, margins, valuation, and 5-year total return — side by side.
Packaged Foods
Packaged Foods
Packaged Foods
NOMD vs CAG vs CPB vs HRL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Packaged Foods | Packaged Foods | Packaged Foods | Packaged Foods |
| Market Cap | $1.44B | $6.86B | $6.34B | $11.41B |
| Revenue (TTM) | $3.03B | $11.18B | $10.04B | $12.14B |
| Net Income (TTM) | $137M | $13M | $550M | $489M |
| Gross Margin | 27.1% | 24.6% | 29.3% | 15.5% |
| Operating Margin | 10.7% | 13.1% | 12.1% | 6.0% |
| Forward P/E | 6.9x | 8.4x | 9.7x | 14.1x |
| Total Debt | $2.29B | $8.31B | $7.21B | $2.86B |
| Cash & Equiv. | $325M | $68M | $132M | $671M |
NOMD vs CAG vs CPB vs HRL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Nomad Foods Limited (NOMD) | 100 | 47.8 | -52.2% |
| Conagra Brands, Inc. (CAG) | 100 | 41.2 | -58.8% |
| Campbell Soup Compa… (CPB) | 100 | 41.7 | -58.3% |
| Hormel Foods Corpor… (HRL) | 100 | 42.5 | -57.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NOMD vs CAG vs CPB vs HRL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NOMD is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.07, Low D/E 91.8%, current ratio 1.07x
- Lower P/E (6.9x vs 14.1x)
CAG has the current edge in this matchup, primarily because of its strength in income & stability and defensive.
- Dividend streak 6 yrs, beta 0.06, yield 9.8%
- Beta 0.06, yield 9.8%, current ratio 0.71x
- Beta 0.06 vs HRL's 0.15
- 9.8% yield, 6-year raise streak, vs HRL's 5.5%
CPB is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 6.4%, EPS growth 6.3%, 3Y rev CAGR 6.2%
- 6.4% revenue growth vs CAG's -4.8%
- 5.5% margin vs CAG's 0.1%
HRL is the clearest fit if your priority is long-term compounding.
- -23.9% 10Y total return vs NOMD's 40.1%
- -24.7% vs NOMD's -43.5%
- 3.7% ROA vs CAG's 0.1%, ROIC 5.3% vs 6.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.4% revenue growth vs CAG's -4.8% | |
| Value | Lower P/E (6.9x vs 14.1x) | |
| Quality / Margins | 5.5% margin vs CAG's 0.1% | |
| Stability / Safety | Beta 0.06 vs HRL's 0.15 | |
| Dividends | 9.8% yield, 6-year raise streak, vs HRL's 5.5% | |
| Momentum (1Y) | -24.7% vs NOMD's -43.5% | |
| Efficiency (ROA) | 3.7% ROA vs CAG's 0.1%, ROIC 5.3% vs 6.0% |
NOMD vs CAG vs CPB vs HRL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NOMD vs CAG vs CPB vs HRL — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CPB leads in 2 of 6 categories
NOMD leads 2 • CAG leads 0 • HRL leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CPB leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HRL is the larger business by revenue, generating $12.1B annually — 4.0x NOMD's $3.0B. CPB is the more profitable business, keeping 5.5% of every revenue dollar as net income compared to CAG's 0.1%. On growth, HRL holds the edge at +1.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $3.0B | $11.2B | $10.0B | $12.1B |
| EBITDAEarnings before interest/tax | $435M | $1.9B | $1.6B | $932M |
| Net IncomeAfter-tax profit | $137M | $13M | $550M | $489M |
| Free Cash FlowCash after capex | $252M | $634M | $919M | $578M |
| Gross MarginGross profit ÷ Revenue | +27.1% | +24.6% | +29.3% | +15.5% |
| Operating MarginEBIT ÷ Revenue | +10.7% | +13.1% | +12.1% | +6.0% |
| Net MarginNet income ÷ Revenue | +4.5% | +0.1% | +5.5% | +4.0% |
| FCF MarginFCF ÷ Revenue | +8.3% | +5.7% | +9.2% | +4.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.6% | -6.8% | -4.5% | +1.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -123.1% | -3.4% | -17.2% | +6.5% |
Valuation Metrics
NOMD leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 6.0x trailing earnings, CAG trades at a 75% valuation discount to HRL's 23.8x P/E. On an enterprise value basis, NOMD's 7.3x EV/EBITDA is more attractive than HRL's 13.8x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $1.4B | $6.9B | $6.3B | $11.4B |
| Enterprise ValueMkt cap + debt − cash | $3.7B | $15.1B | $13.4B | $13.6B |
| Trailing P/EPrice ÷ TTM EPS | 9.46x | 5.95x | 10.57x | 23.84x |
| Forward P/EPrice ÷ next-FY EPS est. | 6.86x | 8.44x | 9.74x | 14.13x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.85x | — | — |
| EV / EBITDAEnterprise value multiple | 7.34x | 8.61x | 7.51x | 13.84x |
| Price / SalesMarket cap ÷ Revenue | 0.40x | 0.59x | 0.62x | 0.94x |
| Price / BookPrice ÷ Book value/share | 0.52x | 0.77x | 1.63x | 1.44x |
| Price / FCFMarket cap ÷ FCF | 4.85x | 5.27x | 8.99x | 21.36x |
Profitability & Efficiency
CPB leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CPB delivers a 14.0% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $0 for CAG. HRL carries lower financial leverage with a 0.36x debt-to-equity ratio, signaling a more conservative balance sheet compared to CPB's 1.85x. On the Piotroski fundamental quality scale (0–9), CPB scores 7/9 vs NOMD's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.3% | +0.2% | +14.0% | +4.3% |
| ROA (TTM)Return on assets | +2.2% | +0.1% | +3.7% | +3.7% |
| ROICReturn on invested capital | +5.5% | +6.0% | +9.1% | +5.3% |
| ROCEReturn on capital employed | +6.2% | +8.2% | +11.4% | +6.0% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.92x | 0.93x | 1.85x | 0.36x |
| Net DebtTotal debt minus cash | $2.0B | $8.2B | $7.1B | $2.2B |
| Cash & Equiv.Liquid assets | $325M | $68M | $132M | $671M |
| Total DebtShort + long-term debt | $2.3B | $8.3B | $7.2B | $2.9B |
| Interest CoverageEBIT ÷ Interest expense | 2.52x | 1.56x | 3.14x | 6.44x |
Total Returns (Dividends Reinvested)
NOMD leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CPB five years ago would be worth $5,806 today (with dividends reinvested), compared to $4,026 for NOMD. Over the past 12 months, HRL leads with a -24.7% total return vs NOMD's -43.5%. The 3-year compound annual growth rate (CAGR) favors NOMD at -15.8% vs CPB's -22.0% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -15.4% | -13.0% | -20.5% | -8.8% |
| 1-Year ReturnPast 12 months | -43.5% | -31.5% | -35.4% | -24.7% |
| 3-Year ReturnCumulative with dividends | -40.3% | -50.8% | -52.6% | -40.5% |
| 5-Year ReturnCumulative with dividends | -59.7% | -44.3% | -41.9% | -44.3% |
| 10-Year ReturnCumulative with dividends | +40.1% | -27.9% | -44.9% | -23.9% |
| CAGR (3Y)Annualised 3-year return | -15.8% | -21.1% | -22.0% | -15.9% |
Risk & Volatility
Evenly matched — CPB and HRL each lead in 1 of 2 comparable metrics.
Risk & Volatility
CPB is the less volatile stock with a -0.02 beta — it tends to amplify market swings less than HRL's 0.15 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HRL currently trades 65.1% from its 52-week high vs NOMD's 51.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.07x | 0.06x | -0.02x | 0.15x |
| 52-Week HighHighest price in past year | $19.71 | $23.47 | $36.16 | $31.86 |
| 52-Week LowLowest price in past year | $9.17 | $13.61 | $19.76 | $20.32 |
| % of 52W HighCurrent price vs 52-week peak | +51.3% | +61.1% | +58.8% | +65.1% |
| RSI (14)Momentum oscillator 0–100 | 58.6 | 36.1 | 46.7 | 39.5 |
| Avg Volume (50D)Average daily shares traded | 1.6M | 14.1M | 9.1M | 4.2M |
Analyst Outlook
Evenly matched — CAG and HRL each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NOMD as "Buy", CAG as "Hold", CPB as "Hold", HRL as "Hold". Consensus price targets imply 33.4% upside for NOMD (target: $14) vs 21.6% for CPB (target: $26). For income investors, CAG offers the higher dividend yield at 9.75% vs HRL's 5.54%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $13.50 | $17.55 | $25.83 | $27.25 |
| # AnalystsCovering analysts | 13 | 25 | 29 | 29 |
| Dividend YieldAnnual dividend ÷ price | +7.1% | +9.8% | +7.2% | +5.5% |
| Dividend StreakConsecutive years of raises | 2 | 6 | 1 | 34 |
| Dividend / ShareAnnual DPS | $0.61 | $1.40 | $1.53 | $1.15 |
| Buyback YieldShare repurchases ÷ mkt cap | +16.5% | +0.9% | +1.0% | 0.0% |
CPB leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NOMD leads in 2 (Valuation Metrics, Total Returns). 2 tied.
NOMD vs CAG vs CPB vs HRL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NOMD or CAG or CPB or HRL a better buy right now?
For growth investors, Campbell Soup Company (CPB) is the stronger pick with 6.
4% revenue growth year-over-year, versus -2. 2% for Nomad Foods Limited (NOMD). Conagra Brands, Inc. (CAG) offers the better valuation at 6. 0x trailing P/E (8. 4x forward), making it the more compelling value choice. Analysts rate Nomad Foods Limited (NOMD) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NOMD or CAG or CPB or HRL?
On trailing P/E, Conagra Brands, Inc.
(CAG) is the cheapest at 6. 0x versus Hormel Foods Corporation at 23. 8x. On forward P/E, Nomad Foods Limited is actually cheaper at 6. 9x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — NOMD or CAG or CPB or HRL?
Over the past 5 years, Campbell Soup Company (CPB) delivered a total return of -41.
9%, compared to -59. 7% for Nomad Foods Limited (NOMD). Over 10 years, the gap is even starker: NOMD returned +40. 1% versus CPB's -44. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NOMD or CAG or CPB or HRL?
By beta (market sensitivity over 5 years), Campbell Soup Company (CPB) is the lower-risk stock at -0.
02β versus Hormel Foods Corporation's 0. 15β — meaning HRL is approximately -966% more volatile than CPB relative to the S&P 500. On balance sheet safety, Hormel Foods Corporation (HRL) carries a lower debt/equity ratio of 36% versus 185% for Campbell Soup Company — giving it more financial flexibility in a downturn.
05Which is growing faster — NOMD or CAG or CPB or HRL?
By revenue growth (latest reported year), Campbell Soup Company (CPB) is pulling ahead at 6.
4% versus -2. 2% for Nomad Foods Limited (NOMD). On earnings-per-share growth, the picture is similar: Campbell Soup Company grew EPS 6. 3% year-over-year, compared to -40. 8% for Hormel Foods Corporation. Over a 3-year CAGR, CPB leads at 6. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NOMD or CAG or CPB or HRL?
Conagra Brands, Inc.
(CAG) is the more profitable company, earning 9. 9% net margin versus 4. 0% for Hormel Foods Corporation — meaning it keeps 9. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CPB leads at 13. 2% versus 5. 9% for HRL. At the gross margin level — before operating expenses — CPB leads at 30. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NOMD or CAG or CPB or HRL more undervalued right now?
On forward earnings alone, Nomad Foods Limited (NOMD) trades at 6.
9x forward P/E versus 14. 1x for Hormel Foods Corporation — 7. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NOMD: 33. 4% to $13. 50.
08Which pays a better dividend — NOMD or CAG or CPB or HRL?
All stocks in this comparison pay dividends.
Conagra Brands, Inc. (CAG) offers the highest yield at 9. 8%, versus 5. 5% for Hormel Foods Corporation (HRL).
09Is NOMD or CAG or CPB or HRL better for a retirement portfolio?
For long-horizon retirement investors, Campbell Soup Company (CPB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
02), 7. 2% yield). Both have compounded well over 10 years (CPB: -44. 9%, HRL: -23. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NOMD and CAG and CPB and HRL?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NOMD is a small-cap deep-value stock; CAG is a small-cap deep-value stock; CPB is a small-cap deep-value stock; HRL is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.